Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
10.04. | EVERSANA adds AI to medical, legal and regulatory reviews | ||
10.04. | Sun Pharma overturns block on alopecia drug launch in US | ||
10.04. | At-home tablet now an option for NHS bladder cancer patients | ||
10.04. | US government appeals after judge blocks NIH funding cap | ||
10.04. | Cheaper Soliris biosimilars reach the US market | ||
09.04. | Jazz pays $145m to resolve Xyrem antitrust disputes | ||
09.04. | BMS bags a double-quick colorectal cancer approval from FDA | ||
09.04. | CRUK scientists find new tool to test lung cancer therapies | ||
09.04. | Report says US biotech needs $15bn support to fend off China | ||
09.04. | Pharma warns EU of "exodus to US" without reform | ||
08.04. | FDA nod broadens use of Brainomix's stroke AI | ||
08.04. | Rinvoq cleared for giant cell arteritis in EU, ahead of US | ||
08.04. | AZ, Daiichi get EU okay for breast cancer drug Datroway | ||
08.04. | UK unveils £600m investment in health data research | ||
08.04. | EU due to meet with pharma today to discuss tariffs | ||
07.04. | GSK makes fresh neuroscience foray with £2bn+ ABL deal | ||
07.04. | Epsilogen buys rival cancer antibody firm TigaTx | ||
07.04. | Roche preps phase 3 for 'Brainshuttle' Alzheimer's drug | ||
07.04. | Trump blocks plan for Medicare to cover weight-loss drugs | ||
07.04. | Measles claims another life in US - and RFK Jr lauds vaccine | ||
04.04. | Paige's cancer detection AI gets FDA breakthrough status | ||
04.04. | MoonLake secures $500m for lead drug, plus other financings | ||
04.04. | Lilly throws lifeline to Sangamo with $1.4bn licensing deal | ||
04.04. | AZ grabs pair of EU approvals for top cancer drugs | ||
04.04. | Uplizna is first drug FDA-cleared for rare disease IgG4-RD |